MENU
CRSP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CRISPR Therapeutics AG (CRSP) Earnings Date & Reports

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

CRSP is expected to report earnings to rise 10.64% to -103 cents per share on November 04

CRISPR Therapeutics AG CRSP Stock Earnings Reports
Q3'26
Est.
$-1.04
Q2'26
Beat
by $0.26
Q1'26
Missed
by $0.05
Q4'25
Missed
by $0.20
Q3'25
Beat
by $0.09
The last earnings report on August 03 showed earnings per share of -93 cents, beating the estimate of -120 cents. With 646.55K shares outstanding, the current market capitalization sits at 5.23B.
View a ticker or compare two or three
CRSP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of gene-based medicines

Industry Biotechnology

Industry
Biotechnology
Address
Baarerstrasse 14
Phone
+41 415613277
Employees
393
Web
https://www.crisprtx.com